Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02527434
Title Study of Tremelimumab in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult
Covered Countries USA | POL | NLD | BEL

Facility Status City State Zip Country Details
Research Site San Francisco California 94158 United States Details
Research Site Memphis Tennessee 38120 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Brussels 1090 Belgium Details
Research Site Charleroi 6000 Belgium Details
Research Site Wilrijk 2610 Belgium Details
Research Site Daejeon 35015 Korea, Republic of Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 135-710 Korea, Republic of Details
Research Site Groningen 9713 GZ Netherlands Details
Research Site Utrecht 3584 CX Netherlands Details
Research Site Gdańsk 80-214 Poland Details
Research Site Łódź 93-513 Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field